Premium
Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveries
Author(s) -
Fawzy Muhammad,
AbdelHady ElSaid
Publication year - 2010
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2010.02.008
Subject(s) - medicine , misoprostol , obstetrics , abortion , incomplete abortion , pregnancy , vagina , products of conception , gynecology , gestational age , surgery , biology , genetics
Objective To evaluate the safety and efficacy of vaginal misoprostol for second‐trimester abortion in women with 3 or more prior cesarean deliveries. Methods This study was conducted with 138 women who needed pregnancy termination between 13 and 26 gestational weeks, 31 with 3 or more previous cesarean deliveries and 107 with no uterine scars (the controls). Misoprostol was inserted in the vagina every 6 hours until regular contractions or products of conception appeared, a 200‐µg tablet for the first 24 hours and 2 tablets thereafter. The outcomes assessed were successful vaginal abortion, hemorrhage requiring blood transfusion, incomplete abortion, and uterine rupture. Results A vaginal abortion occurred in 28 women (90.3%) in the study group and 107 (100%) in the control group ( P = 0.01). There were no significant differences in the prevalence of the other assessed outcomes. Conclusion Vaginal misoprostol appears to be safe and acceptably effective for second‐trimester pregnancy termination in women with 3 or more previous cesarean deliveries.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom